CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals

All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody

Premium

CBI sources informed that all five will be presented in court on Tuesday afternoon and that the agency will seek police custody.

Mumbai

4 min read Last Updated : Jun 22 2022 | 2:31 AM IST

The Central Bureau of Investigation (CBI) alleged that senior officials of the Central Drugs Standards Control Organisation (CDSCO) colluded with Bengaluru-based pharmaceutical company Biocon Biologics to waive the phase-3 clinical

Topics : CBI Biocon pharmaceutical firms CDSCO Arrested Drug Pharma Companies drug control system Drug companies

First Published: Jun 21 2022 | 8:43 PM IST

Explore News

Stock Market Live Updates Asian Games 2023 Live Updates Stock To Watch Today Latest News Live World Cup Latest News Parliament Special Session Live Parineeti-Raghav Chadha wedding Gold-Silver Price Asian Games Schedule tTday US Federal Reserve Rates

Companies News

GAIL issues tender to buy 1 LNG cargo for October delivery: Reports Nvidia CEO touts India as major AI market in a bid to hedge China risks

Election News

Telangana IT Minister K T Rama Rao accuses PM Modi of misleading youth Court rejects Ashok Gehlot's acquittal plea in defamation case by Shekhawat

India News

Law Minister Meghwal to move Advocate Amendment Bill in Lok Sabha today Special session LIVE: Women's Reservation Bill to be brought in Rajya Sabha

Economy News

Brands seeing increased opportunities to tap into Tier-2, Tier-3 cities India counting on potash supplies despite diplomatic row with Canada

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Continue

Heatmap

CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals

All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody

Also Read

R&D expenditure will rise in the coming quarters: Biocon Biologics MD

Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

Biocon Biologics to go for IPO in 18-24 months: Kiran Mazumdar-Shaw

Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%

Biocon gains 3%, at 6-month high in a weak market; stock up 18% in 3 weeks

Industrialists backing Agnipath should first employ ex-servicemen: Akhilesh

Saving money to skilling soldiers: Agnipath's bold battle plan for military

Recruitment to remain unchanged, regimentation to continue: Tri-services

Agnipath scheme golden opportunity to engage personnel: Welspun chairman

ED quizzes Cong leader Rahul Gandhi for fifth day in National Herald case

Explore News